Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-tri… Grant US-11701362-B2 United States of America 18 Jul 2023
Compositions and methods for treating cancer Grant US-11672801-B2 United States of America 13 Jun 2023
Methods and compositions for treatment of BRAF mutant cancers Grant US-11590133-B2 United States of America 28 Feb 2023
COMBINED TREATMENT FOR CANCER Application WO-2022259242-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2022
Methods and compositions for treating cancer Grant US-11285154-B2 United States of America 29 Mar 2022
COMPOSITION COMPRISING TWO ENZYME INHIBITORS TARGETING TWO DIFFERENT CONFORMATIONS OF AN… Application US-20210186965-A1 United States of America 24 Jun 2021
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-tri… Grant US-10898488-B2 United States of America 26 Jan 2021
Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trich… Grant US-10653697-B2 United States of America 19 May 2020
Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trich… Grant US-10590136-B2 United States of America 17 Mar 2020
Substituted aminopurine compounds, compositions thereof, and methods of treatment… Grant US-10576085-B2 United States of America 03 Mar 2020
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-tri… Application US-10543214-B2 United States of America 28 Jan 2020
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-tri… Application US-10513519-B2 United States of America 24 Dec 2019
METHOD FOR DETERMINING TOLERANCE OF CANCER CELL TO EPIDERMAL GROWTH FACTOR RECEPTOR… Application EP-3450555-A4 European Patent Office 20 Nov 2019
FORMULATIONS OF A COMPOUND MODULATING KINASES Application WO-2019084462-A1 World Intellectual Property Organisation (WIPO) 02 May 2019
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-tri… Application US-10047090-B2 United States of America 14 Aug 2018
PHARMACEUTICAL COMBINATIONS Application WO-2017210538-A1 World Intellectual Property Organisation (WIPO) 07 Dec 2017